| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel intergenic (between REG3A and CTNNA2-AS1)-ALK fusion responds to alectinib in lung adenocarcinoma
|
Liu, Zhenkun
|
|
|
186 |
C |
p.
|
artikel
|
| 2 |
Artificial intelligence-based recurrence prediction outperforms classical histopathological methods in pulmonary adenocarcinoma biopsies
|
Akram, F.
|
|
|
186 |
C |
p.
|
artikel
|
| 3 |
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)
|
Dehem, Agathe
|
|
|
186 |
C |
p.
|
artikel
|
| 4 |
Characterizing Lung-RADS category 4 lesions in a university lung cancer screening program
|
Kocher Wulfeck, Madison
|
|
|
186 |
C |
p.
|
artikel
|
| 5 |
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide
|
Liu, Stephen V.
|
|
|
186 |
C |
p.
|
artikel
|
| 6 |
Clinical factors influencing infectious complications after endobronchial ultrasound-guided transbronchial needle aspiration
|
Uchimura, Keigo
|
|
|
186 |
C |
p.
|
artikel
|
| 7 |
Comment on: Carboplatin and irinotecan (CI) vs. Carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial
|
Furune, Satoshi
|
|
|
186 |
C |
p.
|
artikel
|
| 8 |
Contents
|
|
|
|
186 |
C |
p.
|
artikel
|
| 9 |
Deep learning-based solid component measuring enabled interpretable prediction of tumor invasiveness for lung adenocarcinoma
|
Sun, Jiajing
|
|
|
186 |
C |
p.
|
artikel
|
| 10 |
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
|
Burns, Laura
|
|
|
186 |
C |
p.
|
artikel
|
| 11 |
Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report
|
Schmalz, Lauren
|
|
|
186 |
C |
p.
|
artikel
|
| 12 |
Eligibility for screening with low-dose CT in a real-world cohort of patients with lung cancer in Greece: A brief report
|
Livanou, Maria Effrosyni
|
|
|
186 |
C |
p.
|
artikel
|
| 13 |
Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer
|
Huang, Shujie
|
|
|
186 |
C |
p.
|
artikel
|
| 14 |
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors
|
Manglaviti, Sara
|
|
|
186 |
C |
p.
|
artikel
|
| 15 |
International standards of care in thoracic oncology: A narrative review of clinical quality indicators
|
Nash, Jessica
|
|
|
186 |
C |
p.
|
artikel
|
| 16 |
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
|
Nützinger, Jorn
|
|
|
186 |
C |
p.
|
artikel
|
| 17 |
Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy
|
Dagogo-Jack, Ibiayi
|
|
|
186 |
C |
p.
|
artikel
|
| 18 |
Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP)
|
Sakata, Yoshihiko
|
|
|
186 |
C |
p.
|
artikel
|
| 19 |
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)
|
Garon, Edward B.
|
|
|
186 |
C |
p.
|
artikel
|
| 20 |
Performance of EUS-FNA and EUS-B-FNA for the diagnosis of left adrenal glands metastases in patients with lung cancer: A systematic review and meta-analysis
|
Moretti, Antonio
|
|
|
186 |
C |
p.
|
artikel
|
| 21 |
Quitting smoking improves two-year survival after a diagnosis of non-small cell lung cancer
|
Gemine, Rachel E.
|
|
|
186 |
C |
p.
|
artikel
|
| 22 |
The effect of the introduction of the national lung cancer screening program on short-term mortality in Korea
|
Kim, Woorim
|
|
|
186 |
C |
p.
|
artikel
|
| 23 |
The predictive value of 18F-FDG PET/CT combined with inflammatory index for major pathological reactions in resectable NSCLC receiving neoadjuvant immunochemotherapy
|
Yin, Xiaoqin
|
|
|
186 |
C |
p.
|
artikel
|
| 24 |
Transformation of NSCLC to SCLC harboring EML4–ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review
|
Lingling, Xu
|
|
|
186 |
C |
p.
|
artikel
|
| 25 |
Usefulness of bronchial washing fluid for detection of EGFR mutations in non-small cell lung cancer
|
Ryu, Woo Kyung
|
|
|
186 |
C |
p.
|
artikel
|
Tijdschrift beschrijving